(Q53412221)

14 May 2018

title

Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. (English)

1 reference

14 May 2018

author name string

Hasmall SC

1

1 reference

14 May 2018

James NH

2

1 reference

14 May 2018

Macdonald N

3

1 reference

14 May 2018

Gonzalez FJ

4

1 reference

14 May 2018

Peters JM

5

1 reference

14 May 2018

Roberts RA

6

1 reference

14 May 2018

language of work or name

English

0 references

publication date

1 March 2000

1 reference

14 May 2018

published in

Mutation Research

1 reference

14 May 2018

volume

448

1 reference

14 May 2018

page(s)

193-200

1 reference

14 May 2018

issue

2

1 reference

14 May 2018

Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Quantitation of apoptotic bodies in rat liver by in situ end labelling (ISEL): correlation with morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Induction of early-immediate genes by tumer necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Fatty acid oxidation by human liver peroxisomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Recent update on the PPAR alpha-null mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Programmed cell death in animal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factors NF-kappaB and AP-1 or with expression of tumor necrosis factor alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

Stimulation of DNA synthesis but not of peroxisomal beta-oxidation by nafenopin in primary cultures of marmoset hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0027-5107%2899%2900236-5

10.1016/S0027-5107(99)00236-5

7 January 2021

Identifiers

DOI

1 reference

14 May 2018

PubMed ID

10725472

1 reference

14 May 2018